Page 226 - Full Immunisation Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Full immunisation coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Full Immunisation Coverage Today - Breaking & Trending Today

Cablevision Holding S.A.: Cablevisión Holding announces its Full Year and Fourth Quarter 2020 Results (FY20 and 4Q20)


(1)
BUENOS AIRES, ARGENTINA / ACCESSWIRE / March 10, 2021 / Cablevisión Holding S.A., ( Cablevision Holding , CVH or the Company ) (BCBA:CVH)(LSE:CVH)(OTC PINK:CVHSY), controlling shareholder of Telecom Argentina S.A. (TEO)(TECO2), announced today its full year and fourth quarter 2020 Results. Figures have been prepared in accordance with International Financial Reporting Standards ( IFRS ) and are stated in constant Argentine Pesos ( Ps. or P$ ) as of December 31, 2020, unless otherwise indicated.
The Company s Management has applied IAS 29 (inflation adjustment) in the preparation of these financial statements, following the provisions of Resolution 777/18, issued by the
Comisión Nacional de Valores ( CNV ).
CVH Highlights (2020 vs. 2019): ....

New York , United States , Buenos Aires , Distrito Federal , City Of , United Kingdom , Camilla Ferreira , Grupo Clar , Kostenloser Wertpapierhandel , Medina Manson , Telecom Argentina , Controlling Company , International Financial Reporting Standards , Cablevision Holding , Company Management , Corporate Communications Inc , Regulatory Authority , National Communications Entity , Argentine Pesos , Nacional De Valores , Excluding Depreciation , Net Loss , Total Revenues , Fourth Quarter , Relations Contacts , Investor Relations ,

MeiraGTx Reports Fourth Quarter and Full Year 2020 Financial and Operational Results


MeiraGTx Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
- Preparing to Initiate Phase 3 Lumeos Clinical Trial in AAV-RPGR
- Announced Positive Preliminary Clinical Data from AQUAx AAV-hAQP1 Phase 1 Trial for Treatment of Grade 2/3 Xerostomia
- Completed Build of Internal cGMP Plasmid and DNA Manufacturing Facility
- Strengthened Balance Sheet and Extended Cash Runway into Mid-2023
- First in-vivo Data from Riboswitch Gene Regulation Platform to be Presented in 2021
LONDON and NEW YORK, March 11, 2021 (GLOBE NEWSWIRE) MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial and operational results for the fourth quarter and full year ended December 31, 2020 and provided an update on recent progress. ....

United States , City Of , United Kingdom , Ben Rickles , Company Phase , National Institutes Of Health , Janssen Pharmaceuticals Inc , Drug Administration , Janssen Pharmaceutical Companies Of Johnson , American Academy Of Ophthalmology Annual Meeting , Corporate Development , Meiragtx Holdings , European Society Of Retina Specialists , Preclinical Development Teams , American Society Of Retina Specialists , Clinical Development , Initiate Phase , Clinical Trial , Positive Preliminary Clinical Data , Balance Sheet , Extended Cash Runway , Riboswitch Gene Regulation Platform , Alexandria Forbes , Fast Track , Janssen Pharmaceuticals , Janssen Pharmaceutical Companies ,

SecureWorks Corp.: Secureworks Reports Fourth Quarter and Full Year Fiscal 2021 Results


SecureWorks Corp.: Secureworks Reports Fourth Quarter and Full Year Fiscal 2021 Results
Key Highlights
Nearly 400 customers on cloud-native Secureworks Taegis platform, resulting in annual recurring revenue (ARR) growth for the product of 266 percent since the beginning of the fiscal year, 31 percent from the third quarter to fourth quarter of fiscal year 2021, to end fiscal year 2021 at $55 million.
Secureworks Taegis revenue totaled $32.1 million for fiscal year 2021.
Issuing Secureworks Taegis guidance of at least $150 million ARR by end of fiscal year 2022 and Taegis revenue of $90 to $100 million for fiscal year 2022.
Both GAAP and Non-GAAP full fiscal year 2021 gross margin up 6 percent over prior year. ....

United States , Paul Parrish , Derek Delano , Michaelr Cote , Richie Downum , Secureworks Taegis , Secureworks Global Partner Program , Dell Technologies Inc , Corporate Communications , Dell Inc , Securities Exchange , Partner Program , Quarter Fiscal , Year Fiscal , Extended Detection , Total Economic Impact , Securities Act , Securities Exchange Act , Foreign Corrupt Practices Act , Dell Technologies , Related Financial , Total Net , Stockholder Equity , Cash Flow Information , Tax Cuts , Jobs Act ,

Edison Investment Research Limited: OPG Power Ventures (OPG.L): Initiation


Edison Investment Research Limited: OPG Power Ventures (OPG.L): Initiation - Full power ahead
DJ Edison Investment Research Limited: OPG Power Ventures (OPG.L): Initiation - Full power ahead
Edison Investment Research Limited
Edison Investment Research Limited: OPG Power Ventures (OPG.L): Initiation - Full power ahead
11-March-2021 / 11:41 GMT/BST
=
London, UK, 11 March 2021
OPG Power Ventures (OPG.L): Initiation - Full power ahead
OPG has proved financially resilient through the COVID-19 driven economic slowdown, remaining healthily profitable and
cash generative. As the Indian economy recovers (the OECD is forecasting 12.6% growth in 2021) demand for power will
return. This should drive the recovery in sales and profits, in turn deleveraging the balance sheet, permitting a ....

New York , United States , New South Wales , United Kingdom , Tel Aviv , South Africa , City Of , Noord Holland , David Larkam , Dj Edison Investment Research , Edison Investment Research Limited , Financial Conduct Authority , Investment Research Limited , About Edison , Financial Conduct , Dow Jones Newswires , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , புதியது தெற்கு வேல்ஸ் , ஒன்றுபட்டது கிஂக்டம் , தொலைபேசி அவிவ் , நகரம் ஆஃப் , நூற்த் ஹாலண்ட் , ட்ஜ் எடிசன் முதலீடு ஆராய்ச்சி , எடிசன் முதலீடு ஆராய்ச்சி வரையறுக்கப்பட்டவை , நிதி நடத்தை அதிகாரம் ,